Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) Peptide
Our Local Distributor
北京 101111
Quick Overview for Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) Peptide (ABIN936930)
抗原
宿主
资源
应用范围
-
-
蛋白类型
- Synthetic
-
序列
- ASWVSWGLVK GAEITGKAIQ KGASKLRERI QPEEKPVEVS PAVTKGLYIA
-
产品特性
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SPG20 antibody,
Alternative Names: SPG20 control peptide, SPG20 antibody Blocking Peptide, Anti-SPG20 Blocking Peptide, Spastic Paraplegia 20 Blocking Peptide, Troyer Syndrome Blocking Peptide, KIAA0610 Blocking Peptide, SPARTIN Blocking Peptide, TAHCCP1 Blocking Peptide, SPG20, SPG-20, SPG 20, SPG-20 Blocking Peptide, SPG 20 Blocking Peptide
-
-
-
-
应用备注
- Optimal conditions should be determined by the investigator
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
缓冲液
- PBS
-
注意事项
- Avoid repeated freeze/thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- Store at -20 °C long term.
-
-
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
-
背景
- This gene encodes a protein containing a MIT (Microtubule Interacting and Trafficking molecule) domain, and is implicated in regulating endosomal trafficking and mitochondria function. The protein localizes to mitochondria and partially co-localizes with microtubules. Stimulation with epidermal growth factor (EGF) results in protein translocation to the plasma membrane, and the protein functions in the degradation and intracellular trafficking of EGF receptor. Multiple alternatively spliced variants, encoding the same protein, have been identified.
-
分子量
- 73 kDa
抗原
-